Iris Depaz
From Wikipedia, the free encyclopedia
Iris Depaz | |
|---|---|
| Born | 21 September 1976 |
| Died | 12 August 2024 (aged 47) |
| Occupation | Managing Director |
| Employer | Sanofi |
| Known for | Biotechnology |
| Title | Dr |
Iris Depaz (21 September 1976 – 12 August 2024) was a pharmaceuticals researcher and manager, who was posthumously elected a fellow of the Australian Academy of Technological Sciences and Engineering in 2024,[1] in recognition of her 'influence on creating impact from medical research, bringing it into the clinic'.[1] She was Head of Medical Vaccines and managing director of the Translational Science Hub of Sanofi, in Queensland.[2][3]
Depaz graduated with a Bachelor of Science, Honours, from the University of Queensland in 1998, a Doctor of Philosophy in Molecular Biology, on neuronal drug metabolism and alcohol dependency,[4] from the University of Queensland in 2003, as well as a Graduate Certificate of Higher Education in 2006, also from the University of Queensland.[5] She completed an executive MBA during lockdown in 2020.[5]
Career
Depaz worked in translation and commercialisation of medical research in the scientific community, creating an mRNA technology and translational science community. She was a champion of investing in pharmaceutical companies within Australia, as opposed to losing the Intellectual Property of health technology in overseas developments.[1]
Depaz was previously the Global Head of MSL Centre for Excellence, in Lyon, France. She started as the Pasteur'sHead of Medical at Sanofi, for Australia and New Zealand, in 2021.[4]
Depaz had more than 20 years of global industry experience, and specialist skills in the pharmaceutical and biotechnology sectors.[2] She was previously a director of an AI and block-chain start-up, which focussed on allowing patients to make healthcare decisions which were informed by ownership of their own data.[2]
Depaz was the Founder of the Translational Science Hub,[6] connecting the Queensland Government, Griffith University, and the University of Queensland, with links in France and the USA.[7]
